Description

Robotic production capacity for the pharma manufacturing industryThe traditional manufacturing process for individualized drugs is extremely slow and expensive, because it is based on manual labor. At Multiply Labs, we believe that robotics is the only way to truly scale the production of individualized drugs - finally providing these life-saving therapies to the millions of patients who need them. We develop cloud-controlled modular robotic systems that manufacture individualized drugs, and we deploy these systems in the facilities of our pharma customers. This is pharma robotics as a service: we sell the robotic production capacity that our customers need to scale their next-gen individualized drugs.

 


ACTIVE FOUNDERS

Founder 1

Alice Melocchi, Founder

Twitter: | Linkedin:


Founder 2

Fred Parietti, CEO

Twitter: | Linkedin: https://www.linkedin.com/in/federico-parietti-75164920


Founder 3

,

Twitter: | Linkedin:


Founder 4

,

Twitter: | Linkedin:


Founder 5

,

Twitter: | Linkedin:


Founder 6

,

Twitter: | Linkedin:

Based in

San Francisco

Nation
Team Size

8

Not Available
Today's work schedule is not available
  • Monday

    By appointment only

  • Tuesday

    N/A

  • Wednesday

    N/A

  • Thursday

    N/A

  • Friday

    N/A

  • Saturday

    N/A

  • Sunday

    N/A

  • 4 October 2022 9:09 local time

mood_bad
  • No comments yet.
  • Add a review
      error: Content protected